US 10261095
Predictive biomarkers of clinical response to anti-LPS immunoglobulin treatment
granted A61KA61K2039/505A61P
Quick answer
US patent 10261095 (Predictive biomarkers of clinical response to anti-LPS immunoglobulin treatment) held by Julius-Maximilians-Universitat Wurzburg expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Julius-Maximilians-Universitat Wurzburg
- Grant date
- Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/505, A61P, A61P1/00, A61P1/02